Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease Clinical Trial
Official title:
Multicenter Results of Mitral Valve Surgery in Patients With Rheumatic Heart Disease
| NCT number | NCT04780607 |
| Other study ID # | MARS |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | January 1, 2011 |
| Est. completion date | April 1, 2024 |
rheumatic heart disease remains the majority valvular disease in low and middle income countries, which mostly affected mitral valve, surgical treatment is the most effective strategy to improve the outcomes of middle or late-stage RHD patient, however, whether mitral valve repair surgery is superior to replacement or other evolving interventional device remains controversial, this study aims to investigate the results of repair surgery compared with replacement or other treatment strategy from international multicenters.
| Status | Recruiting |
| Enrollment | 4000 |
| Est. completion date | April 1, 2024 |
| Est. primary completion date | January 1, 2024 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | N/A and older |
| Eligibility | Inclusion Criteria: - 1?rheumatic heart disease 2?mitral valve disease 3?combined with other heart valve disease(aortic valve, tricuspid valve, pulmonary valve) 4?patients underwent initial mitral valve surgery or intervention Exclusion Criteria: - 1?congenital heart disease degenerative heart valve disease 2?isolated aortic valve or tricuspid valve, pulmonary valve disease( doesn't affect mitral valve ) 3?patients received more than 1 time mitral valve operation |
| Country | Name | City | State |
|---|---|---|---|
| China | Beijing Anzhen Hospital | Beijing | Beijing |
| Lead Sponsor | Collaborator |
|---|---|
| Beijing Anzhen Hospital |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | all-cause mortality | death from any cause | 2011-2024 |